Cargando…
Relevance of mortalin to cancer cell stemness and cancer therapy
Mortalin/mtHsp70 is a member of Hsp70 family of proteins. Enriched in a large variety of cancers, it has been shown to contribute to the process of carcinogenesis by multiple ways including inactivation of tumor suppressor p53 protein, deregulation of apoptosis and activation of EMT signaling. In th...
Autores principales: | Yun, Chae-Ok, Bhargava, Priyanshu, Na, Youjin, Lee, Jung-Sun, Ryu, Jihoon, Kaul, Sunil C., Wadhwa, Renu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292728/ https://www.ncbi.nlm.nih.gov/pubmed/28165047 http://dx.doi.org/10.1038/srep42016 |
Ejemplares similares
-
Why is Mortalin a Potential Therapeutic Target for Cancer?
por: Yoon, A-Rum, et al.
Publicado: (2022) -
Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers
por: Putri, Jayarani F., et al.
Publicado: (2019) -
Mortalin deficiency suppresses fibrosis and induces apoptosis in keloid spheroids
por: Lee, Won Jai, et al.
Publicado: (2017) -
Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells
por: Nigam, Nupur, et al.
Publicado: (2015) -
Novel Caffeic Acid Phenethyl Ester-Mortalin Antibody Nanoparticles Offer Enhanced Selective Cytotoxicity to Cancer Cells
por: Wang, Jia, et al.
Publicado: (2020)